Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial

By Naber Dieter   Greenspan Andrew   Schreiner Andreas  

Psychopharmacology, Vol. 191, Iss. 4, 2007-05 ,pp. : 1027-1029

Springer Publishing Company

Access to resources Recommend Favorite

Topical 5% Lidocaine (Lignocaine) Medicated Plaster Treatment for Post-Herpetic Neuralgia: Results of a Double-Blind, Placebo-Controlled, Multinational Efficacy and Safety Trial

By Binder Andreas  

Clinical Drug Investigation, Vol. 29, Iss. 6, 2009-05 ,pp. : 393-408

Adis International

Access to resources Recommend Favorite

Efficacy of Zolmitriptan at Early Time-Points for the Acute Treatment of Migraine and Treatment of Recurrence: A Randomised, Placebo-Controlled Trial

By Ryan R.E.J.  

CNS Drugs, Vol. 13, Iss. 3, 2000-03 ,pp. : 215-226

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Nebulized Formoterol as Add-on Therapy in COPD Patients Receiving Maintenance Tiotropium Bromide: Results from a 6-Week, Randomized, Placebo-Controlled, Clinical Trial

By Hanania Nicola A.  

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1205-1216

Adis International

Access to resources Recommend Favorite

Nicergoline in the long term treatment of mild or moderate senile dementia. A multicenter double-blind, randomized, placebo-controlled trial

By Nicergoline Dementia Long Term Study Italian Group   Battaglia A.   Annoni K.   Pamparana F.   De Paolis C.   Bonura M.L.   Stekke W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 383-383

Elsevier

Access to resources Recommend Favorite